Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- US swim star's coach fights for life with rare disorder: report
- MIAMI AFP — US swimmer Dara Torres, set for her fifth Olympics next month in Beijing at age 41, is devastated as her coach for the past two years, Michael Lohberg, faces an unexpected fight for his life. Lohberg was set to leave for Singapore on Friday but the...
- Research articles 2008-07-24
- Vince Fumo released from hospital
- HARRISBURG - State Sen. Vincent J. Fumo (D., Phila.) was discharged from a hospital yesterday morning after suffering a spell of dizziness and collapsing on the Senate floor late Thursday afternoon. Doctors at Harrisburg Hospital said the collapse was caused by a combination of factors, including slight anemia, low blood...
- Research articles 2008-06-28
- Positive Clinical Data for PBI-1402 Presented at the Annual Congress of the European Hematology Association
- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") today presented results on its orally-active PBI-1402 compound in clinical trial in patients with chemotherapy-induced anemia ("CIA") at the 13th Congress of the European Hematology Association held in Copenhagen, Denmark this week. Dr. Lyne Gagnon, ProMetic's Director R&D, Biology, presented data on...
- Research articles 2008-06-14
- AMAG Pharmaceuticals, Inc. Added to NASDAQ Biotech Index
- CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) a biotechnology company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today announced that it has been selected...
- Research articles 2008-05-12
- ProMetic Life Sciences Inc.: Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial
- ProMetic Life Sciences Inc. (TSX: PLI)("ProMetic") announces that oral PBI-1402 demonstrates significant activity in patients with chemotherapy-induced anemia ("CIA"), and reduces the need for red blood cell ("RBC") transfusion. Only 2 patients out of 28 (7%) treated with PBI-1402 required a RBC transfusion, a response rate greater than 90%...
- Research articles 2008-04-23
- Prometic Reports Continued Positive Data in PBI-1402 PHASE II Trial in Chemotherapy-Induced Anemia; Update on Clinical Developments.
- MONTREAL, QUEBEC, Mar 6, 2008 Marketwire via COMTEX -- ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announces favorable top-line findings from the third cohort in its Phase II trial with PBI-1402 in patients with chemotherapy-induced anemia ("CIA"). Analysis of the compiled data from a total of 18...
- Research articles 2008-03-06
- Prometic Reports Continued Positive Data in PBI-1402 PHASE II Trial in Chemotherapy-Induced Anemia
- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announces favorable top-line findings from the third cohort in its Phase II trial with PBI-1402 in patients with chemotherapy-induced anemia ("CIA"). Analysis of the compiled data from a total of 18 patients showed an overall statistically significant increase of the mean hematocrit values...
- Research articles 2008-03-06
- Overweight toddlers most at risk
- Overweight toddlers and those not enrolled in day care are at high risk for iron deficiency, maintain nutritional researchers at the University of Texas Southwestern Medical Center, Dallas. Based on data from a national survey, their study states that 20% of overweight toddlers are iron-deficient, compared to eight percent of...
- Research articles 2008-02-01
- AMAG Pharmaceuticals, Inc. Reports on Progress Toward Commercialization and Discusses Key Activities for 2008 at 26th Annual JPMorgan Healthcare Conference
- CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and CEO of AMAG Pharmaceuticals, Inc., will provide a company update at the 26th Annual JPMorgan Healthcare Conference at 11:00 a.m. PT on Tuesday, January 8, 2008, at the Westin St. Francis Hotel in...
- Research articles 2008-01-08
- Prometic Provides Business Update and Reports Financial Results for the Period Ended September 30, 2007; - Abstract on PBI-1402 data posted on American Society of Hematology's web site - Pre-adoption trials underway in Ireland and in the UK for P-Capt(R)
- MONTREAL, QUEBEC, Nov 14, 2007 Marketwire via COMTEX -- ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today provided an update on PBI-1402 and on protein technologies business activities, 2008 financial guidance, near term milestones, and reported financial results for the three and nine months ended September 30,...
- Research articles 2007-11-14
- Prometic Provides Business Update and Reports Financial Results for the Period Ended September 30, 2007
- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") today provided an update on PBI-1402 and on protein technologies business activities, 2008 financial guidance, near term milestones, and reported financial results for the three and nine months ended September 30, 2007. "The company has made significant progress throughout 2007 with impressive...
- Research articles 2007-11-14
- ProMetic's PBI-1402 Abstract Available Through American Society of Hematology's Web Site
- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announced today that ProMetic's abstract on its PBI-1402 Phase II clinical trial in patients with chemotherapy-induced anemia ("CIA") is now available on the American Society of Hematology's ("ASH") Web site under the heading "Annual Meeting Abstracts" http://www.hematology.org/meetings/2007/index.cfm . More substantive information...
- Research articles 2007-11-13
- ProMetic's PBI-1402 Abstract Available Through American Society of Hematology's Web Site.(Website overview)
- MONTREAL, QUEBEC, Nov 13, 2007 Marketwire via COMTEX -- ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announced today that ProMetic's abstract on its PBI-1402 Phase II clinical trial in patients with chemotherapy-induced anemia ("CIA") is now available on the American Society of Hematology's ("ASH") Web site...
- Research articles 2007-11-13
- ProMetic to Report Results of PBI-1402 Clinical Trial at Upcoming Annual Meeting of American Society of Hematology
- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announced today that ProMetic has been selected by the American Society of Hematology ("ASH") to present data from its PBI-1402 clinical trial in patients with chemotherapy-induced anemia ("CIA") at its 49th Annual Meeting, being held from December 8 to 11, 2007, in Atlanta,...
- Research articles 2007-10-04
- ProMetic to Report Results of PBI-1402 Clinical Trial at Upcoming Annual Meeting of American Society of Hematology.(Clinical report)
- MONTREAL, QUEBEC, Oct 4, 2007 Marketwire via COMTEX -- ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announced today that ProMetic has been selected by the American Society of Hematology ("ASH") to present data from its PBI-1402 clinical trial in patients with chemotherapy-induced anemia ("CIA") at its 49th...
- Research articles 2007-10-04
- Little Ambassador meets the President
- President George W. Bush welcomes 2007 March of Dimes National Ambassador Ezekiel "Zeek" Taylor, 8, of Durham, NC, to the White House Oval Office. Taylor has been touring the United States with his family speaking on behalf of the March of Dimes and its efforts to improve the health of...
- Research articles 2007-08-20
- ProMetic Life Sciences Inc. Sparks Interest in Current Events.
- M2 PRESSWIRE-11 July 2007-www.streetinvesting.com: ProMetic Life Sciences Inc. Sparks Interest in Current EventsC1994-2007 M2 COMMUNICATIONS LTD RDATE:11072007 Streetinvesting.com is the leading online financial newsletter community with thousands of investors from around the world. Our goal is to bring our theories...
- Research articles 2007-07-11
- ProMetic Reports Positive Preliminary Phase Ib/II Data for PBI-1402 in Chemotherapy-Induced Anemia.
- MONTREAL, QUEBEC, Jul 10, 2007 CCNMatthews via COMTEX -- ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announces preliminary data from a Phase Ib/II trial with its orally active drug PBI-1402 for the treatment of chemotherapy-induced anemia CIA. Data highlights include: - Clinical activity confirmed...
- Research articles 2007-07-10
- BioLink Life Sciences
- BioLink Life Sciences, a Cary-based boutique pharma company that "repairs" registered drugs, announced funding of a phase 1 SBIR grant from the U.S. Department of Agriculture to support BioLink's development of a novel oral iron supplement for people with iron deficiency anemia.
- Research articles 2007-07-01
- Neose Receives FDA Clearance to Commence U.S. Clinical Trials for NE-180.
- M2 PRESSWIRE-15 March 2007-Morning Movers: Neose Receives FDA Clearance to Commence U.S. Clinical Trials for NE-180C1994-2007 M2 COMMUNICATIONS LTD RDATE:15032007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of...
- Research articles 2007-03-15
- << Previous
- page 1 of 3
- Next >>
Content Types
Refining Tags
- patient (18 results)
- CIA (13 results)
- HEALTHCARE (9 results)
- SOFTWARE (8 results)
- Finance (6 results)
- FDA (5 results)
- Benefits (5 results)
- Amgen Inc. (5 results)
- American Society of Hematology (5 results)
- Nasdaq Stock Market Inc. (5 results)
- Company (5 results)
- Government (4 results)
- Manufacturing (4 results)
- Aranesp (3 results)
- Web (3 results)
